A. Neugut, J. Jacobson, and S. Suh, The epidemiology of cancer of the small bowel, Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. mars, vol.7, issue.3, pp.243-51, 1998.

C. Lepage, A. Bouvier, and S. Manfredi, Incidence and Management of Primary Malignant Small Bowel Cancers: A Well-defined French Population Study, The American Journal of Gastroenterology, vol.14, issue.5, pp.2826-2858, 2006.
DOI : 10.1016/S0959-8049(96)00244-4

A. Stang, C. Stegmaier, and B. Eisinger, Descriptive epidemiology of small intestinal malignancies: the German Cancer Registry experience, British Journal of Cancer, vol.80, issue.9, pp.1440-1444, 1999.
DOI : 10.1038/sj.bjc.6690541

K. Bilimoria, D. Bentrem, and J. Wayne, Small Bowel Cancer in the United States, Annals of Surgery, vol.249, issue.1, pp.63-71, 2009.
DOI : 10.1097/SLA.0b013e31818e4641

Y. Moon, S. Rha, and S. Shin, Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators, Journal of Cancer Research and Clinical Oncology, vol.151, issue.3, pp.387-94, 2009.
DOI : 10.1007/s00432-009-0668-3

T. Aparicio, S. Manfredi, and D. Tougeron, NADEGE prospective cohort: demographic data of 343 patients with small bowel adenocarcinoma, Eur Cancer Congress, vol.34, pp.6-7, 2013.

M. Overman, S. Kopetz, and E. Lin, Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine, Acta Oncologica, vol.147, issue.4, pp.474-483, 2010.
DOI : 10.1001/archsurg.137.5.564

K. Pedersen, T. Smyrk, S. Harrington, and D. , Programmed death-ligand 1 (PD-L1) expression in small bowel adenocarcinomas (SBA), J Clin Oncol, vol.3619, 2015.

J. Howe, L. Karnell, and H. Menck, Adenocarcinoma of the small bowel, Cancer, vol.180, issue.12, pp.2693-706, 1985.
DOI : 10.1002/(SICI)1097-0142(19991215)86:12<2693::AID-CNCR14>3.0.CO;2-U

J. Faivre, A. Trama, and R. Angelis, Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995???2002, European Journal of Cancer, vol.48, issue.10, pp.1417-1441, 2011.
DOI : 10.1016/j.ejca.2011.10.038

URL : https://hal.archives-ouvertes.fr/hal-00719134

T. Halfdanarson, R. M. Robert, and J. Donohue, A single-institution experience with 491 cases of small bowel adenocarcinoma, The American Journal of Surgery, vol.199, issue.6, pp.797-803, 2010.
DOI : 10.1016/j.amjsurg.2009.05.037

T. Tsushima, M. Taguri, and Y. Honma, Multicenter retrospective study of 132 patients with unresectable small bowel adenocarcinoma treated with chemotherapy. The oncologist, pp.1163-70, 2012.

A. Zaanan, L. Costes, and M. Gauthier, Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study, Annals of Oncology, vol.21, issue.9, pp.1786-93, 2010.
DOI : 10.1093/annonc/mdq038

URL : https://hal.archives-ouvertes.fr/hal-00618071

I. Hatzaras, J. Palesty, and F. Abir, Small-Bowel Tumors, Archives of Surgery, vol.142, issue.3, pp.229-264, 2007.
DOI : 10.1001/archsurg.142.3.229

A. Jemal, R. Siegel, and E. Ward, Cancer Statistics, 2008, CA: A Cancer Journal for Clinicians, vol.58, issue.2, pp.71-96, 2008.
DOI : 10.3322/CA.2007.0010

J. Chow, C. Chen, and H. Ahsan, A Population-Based Study of the Incidence of Malignant Small Bowel Tumours: SEER, 1973???1990, International Journal of Epidemiology, vol.25, issue.4, pp.722-730, 1996.
DOI : 10.1093/ije/25.4.722

B. Dabaja, D. Suki, and B. Pro, Adenocarcinoma of the small bowel, Cancer, vol.101, issue.3, pp.518-544, 2004.
DOI : 10.1002/cncr.20404

P. Vanessa, A. Bouvier, and J. Cosnes, Small bowel adenocarcinoma in patients with Crohn's disease compared with small bowel adenocarcinoma de novo, Inflamm Bowel Dis, vol.11, issue.9, pp.828-860, 2005.

M. Overman, C. Hu, and S. Kopetz, A Population-Based Comparison of Adenocarcinoma of the Large and Small Intestine: Insights Into a Rare Disease, Annals of Surgical Oncology, vol.28, issue.5, pp.1439-1484, 2012.
DOI : 10.1245/s10434-011-2173-6

M. Talamonti, L. Goetz, and S. Rao, Primary Cancers of the Small Bowel, Archives of Surgery, vol.137, issue.5, pp.564-71, 2002.
DOI : 10.1001/archsurg.137.5.564

T. Aparicio, S. Manfredi, and D. Tougeron, Cohorte NADEGE: données démographiques sur 343 patients atteints d'adénocarcinome de l'intestin grêle, JFHOD, vol.007799, 2014.

T. Aparicio, A. Zaanan, and M. Svrcek, Small bowel adenocarcinoma: Epidemiology, risk factors, diagnosis and treatment, Digestive and Liver Disease, vol.46, issue.2, 2013.
DOI : 10.1016/j.dld.2013.04.013

A. Wu, M. Yu, and T. Mack, Smoking, alcohol use, dietary factors and risk of small intestinal adenocarcinoma, International Journal of Cancer, vol.43, issue.5, pp.512-519, 1997.
DOI : 10.1002/(SICI)1097-0215(19970304)70:5<512::AID-IJC4>3.0.CO;2-0

L. Kaerlev, P. Teglbjaerg, and S. Sabroe, Is there an association between alcohol intake or smoking and small bowel adenocarcinoma? Results from a European multi-center casecontrol study, Cancer Causes and Control, vol.11, issue.9, pp.791-798, 2000.
DOI : 10.1023/A:1008920502888

W. Chow, M. Linet, and J. M. , Risk factors for small intestine cancer, Cancer Causes and Control, vol.1, issue.2, pp.163-172, 1993.
DOI : 10.1007/BF00053158

E. Negri, C. Bosetti, and C. Vecchia, Risk factors for adenocarcinoma of the small intestine, International Journal of Cancer, vol.70, issue.2, pp.171-175, 1999.
DOI : 10.1002/(SICI)1097-0215(19990719)82:2<171::AID-IJC3>3.0.CO;2-T

T. Delaunoit, F. Neczyporenko, and P. Limburg, Pathogenesis and Risk Factors of Small Bowel Adenocarcinoma: A Colorectal Cancer Sibling?, The American Journal of Gastroenterology, vol.13, issue.3, pp.703-713, 2005.
DOI : 10.1016/0002-9610(78)90158-7

H. Bläker, B. Helmchen, and A. Bönisch, Mutational activation of the RAS???RAF???MAPK and the wnt pathway in small intestinal adenocarcinomas, Scandinavian Journal of Gastroenterology, vol.56, issue.8, pp.748-53, 2004.
DOI : 10.1080/00365520410005847

J. Wheeler, B. Warren, and N. Mortensen, An insight into the genetic pathway of adenocarcinoma of the small intestine, Gut, vol.50, issue.2, pp.218-241, 2002.
DOI : 10.1136/gut.50.2.218

M. Arai, S. Shimizu, and Y. Imai, Mutations of the Ki???ras, p53 and APC genes in adenocarcinomas of the human small intestine, International Journal of Cancer, vol.70, issue.4, pp.390-395, 1997.
DOI : 10.1002/(SICI)1097-0215(19970207)70:4<390::AID-IJC3>3.3.CO;2-S

H. Bläker, A. Von-herbay, and R. Penzel, Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene, Oncogene, vol.59, issue.1, pp.158-64, 2002.
DOI : 10.1038/sj.onc.1205041

T. Aparicio, M. Svrcek, and A. Zaanan, Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study, British Journal of Cancer, vol.7, issue.12, pp.3057-66, 2013.
DOI : 10.1002/(SICI)1096-9098(199602)61:2<100::AID-JSO3>3.0.CO;2-G

K. Breuhahn, S. Singh, and P. Schirmacher, Large-scale N-terminal deletions but not point mutations stabilize ??-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis, The Journal of Pathology, vol.15, issue.3, pp.300-307, 2008.
DOI : 10.1002/path.2362

M. Svrcek, J. F. Sebbagh, and N. , Immunohistochemical analysis of adenocarcinoma of the small intestine: a tissue microarray study, Journal of Clinical Pathology, vol.56, issue.12, pp.898-903, 2003.
DOI : 10.1136/jcp.56.12.898

A. Laforest, T. Aparicio, and A. Zaanan, ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma, European Journal of Cancer, vol.50, issue.10, pp.1740-1746, 2014.
DOI : 10.1016/j.ejca.2014.04.007

T. Aparicio, M. Svreck, and A. Laforest, Small Bowel Adenocarcinoma Phenotype According To The Primary Localisation, Annals of Oncology, vol.23, issue.9, pp.234-235, 2012.

M. Overman, J. Pozadzides, and S. Kopetz, Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine, British Journal of Cancer, vol.61, issue.1, pp.144-50, 2010.
DOI : 10.1038/sj.bjc.6605449

M. Planck, K. Ericson, and Z. Piotrowska, Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine, Cancer, vol.65, issue.6, pp.1551-1558, 2003.
DOI : 10.1002/cncr.11197

E. Lipson, W. Sharfman, and C. Drake, Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody, Clinical Cancer Research, vol.19, issue.2, pp.462-470, 2013.
DOI : 10.1158/1078-0432.CCR-12-2625

D. Le, J. Uram, and H. Wang, PD-1 Blockade in Tumors with Mismatch-Repair Deficiency, New England Journal of Medicine, vol.372, issue.26, pp.2509-2529, 2015.
DOI : 10.1056/NEJMoa1500596

J. Haan, T. Buffart, and P. Eijk, Small bowel adenocarcinoma copy number profiles are more closely related to colorectal than to gastric cancers, Annals of Oncology, vol.23, issue.2, pp.367-74, 2012.
DOI : 10.1093/annonc/mdr122

G. Offerhaus, F. Giardiello, and A. Krush, The risk of upper gastrointestinal cancer in familial adenomatous polyposis, Gastroenterology, vol.102, issue.6, 1992.
DOI : 10.1016/0016-5085(92)90322-P

D. Jagelman, J. Decosse, and H. Bussey, UPPER GASTROINTESTINAL CANCER IN FAMILIAL ADENOMATOUS POLYPOSIS, The Lancet, vol.331, issue.8595, pp.1149-51, 1988.
DOI : 10.1016/S0140-6736(88)91962-9

S. Bülow, T. Alm, and O. Fausa, Duodenal adenomatosis in familial adenomatous polyposis, International Journal of Colorectal Disease, vol.14, issue.1, pp.43-49, 1995.
DOI : 10.1007/BF00337586

H. Vasen, J. Wijnen, and F. Menko, Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis, Gastroenterology, vol.110, issue.4, pp.1020-1027, 1996.
DOI : 10.1053/gast.1996.v110.pm8612988

V. Bonadona, B. Bonaïti, and S. Olschwang, French Cancer Genetics Network. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome, JAMA. 8 juin, vol.305, issue.22, pp.2304-2314, 2011.

J. Saurin, F. Pilleul, and E. Soussan, Small-bowel capsule endoscopy diagnoses early and advanced neoplasms in asymptomatic patients with Lynch syndrome, Endoscopy, vol.42, issue.12, pp.1057-62, 2010.
DOI : 10.1055/s-0030-1255742

H. Vasen, I. Blanco, and K. Aktan-collan, Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts, Gut, vol.62, issue.6, pp.812-835, 2013.
DOI : 10.1136/gutjnl-2012-304356

T. Babba, O. Schischmanoff, and C. Lagorce, Small bowel carcinoma revealing HNPCC syndrome, Gastroent??rologie Clinique et Biologique, vol.34, issue.4-5, pp.4-5325, 2010.
DOI : 10.1016/j.gcb.2010.04.007

F. Giardiello, J. Brensinger, and A. Tersmette, Very high risk of cancer in familial Peutz???Jeghers syndrome, Gastroenterology, vol.119, issue.6, pp.1447-53, 2000.
DOI : 10.1053/gast.2000.20228

C. Bernstein, J. Blanchard, and E. Kliewer, Cancer risk in patients with inflammatory bowel disease, Cancer, vol.77, issue.4, pp.854-62, 2001.
DOI : 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z

G. Piton, J. Cosnes, and E. Monnet, P071 RISK FACTORS ASSOCIATED WITH SMALL BOWEL ADENOCARCINOMA IN CROHN'S DISEASE: A CASE-CONTROL STUDY, Journal of Crohn's and Colitis Supplements, vol.1, issue.1, pp.1730-1736, 2008.
DOI : 10.1016/S1873-9954(07)70083-6

J. Askling, M. Linet, and G. Gridley, Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis, Gastroenterology, vol.123, issue.5, pp.1428-1463, 2002.
DOI : 10.1053/gast.2002.36585

T. Wu, C. Yeh, and T. Chao, Prognostic Factors of Primary Small Bowel Adenocarcinoma: Univariate and Multivariate Analysis, World Journal of Surgery, vol.101, issue.3, pp.391-399, 2006.
DOI : 10.1007/s00268-005-7898-6

M. Nicholl, V. Ahuja, and W. Conway, Small Bowel Adenocarcinoma: Understaged and Undertreated?, Annals of Surgical Oncology, vol.113, issue.10, pp.2728-2760, 2010.
DOI : 10.1245/s10434-010-1109-x

M. Overman, C. Hu, and R. Wolff, Prognostic value of lymph node evaluation in small bowel adenocarcinoma, Cancer, vol.27, issue.23, pp.5374-82, 2010.
DOI : 10.1002/cncr.25324

I. Kaklamanos, O. Bathe, and D. Franceschi, Extent of resection in the management of duodenal adenocarcinoma, The American Journal of Surgery, vol.179, issue.1, pp.37-41, 2000.
DOI : 10.1016/S0002-9610(99)00269-X

T. Sohn, K. Lillemoe, and J. Cameron, Adenocarcinoma of the duodenum: factors influencing long-term survival, Journal of Gastrointestinal Surgery, vol.2, issue.1, pp.79-87, 1998.
DOI : 10.1016/S1091-255X(98)80107-8

K. Khan, C. Peckitt, and F. Sclafani, Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): The Royal Marsden Hospital (RMH) experience, BMC Cancer, vol.17, issue.4, 2015.
DOI : 10.1007/s10120-013-0328-9

D. Koo, S. Yun, and Y. Hong, Systemic chemotherapy for treatment of advanced small bowel adenocarcinoma with prognostic factor analysis: retrospective study, BMC Cancer, vol.27, issue.16, 2011.
DOI : 10.1200/JCO.2008.19.7145

L. Zhang, L. Wang, and Y. Deng, Efficacy of the FOLFOX/CAPOX regimen for advanced small bowel adenocarcinoma: a three-center study from China, J BUON Off J Balk Union Oncol. déc, vol.16, issue.4, pp.689-96, 2011.

A. Zaanan, M. Gauthier, and D. Malka, Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy, Cancer, vol.9, issue.7, pp.1422-1430, 2011.
DOI : 10.1002/cncr.25614

M. Overman, S. Kopetz, and S. Wen, Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma, Cancer, vol.134, issue.8, pp.2038-2083, 2008.
DOI : 10.1002/cncr.23822

P. Czaykowski and D. Hui, Chemotherapy in Small Bowel Adenocarcinoma: 10-year Experience of the British Columbia Cancer Agency, Clinical Oncology, vol.19, issue.2, pp.143-152, 2007.
DOI : 10.1016/j.clon.2006.12.001

X. Xiang, Y. Liu, and L. Zhang, A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma, Anti-Cancer Drugs, vol.23, issue.5, pp.561-567, 2012.
DOI : 10.1097/CAD.0b013e328350dd0d

R. Mcwilliams, M. Mahoney, and B. Marchello, Pharmacogenetic dosing by UGT1A1 genotype as first-line therapy for advanced small-bowel adenocarcinoma: A North Central Cancer Treatment Group (NCCTG) trial., Journal of Clinical Oncology, vol.30, issue.4_suppl, 2012.
DOI : 10.1200/jco.2012.30.4_suppl.314

M. Overman, G. Varadhachary, and S. Kopetz, Phase II Study of Capecitabine and Oxaliplatin for Advanced Adenocarcinoma of the Small Bowel and Ampulla of Vater, Journal of Clinical Oncology, vol.27, issue.16, pp.2598-603, 2009.
DOI : 10.1200/JCO.2008.19.7145

M. Gibson, C. Holcroft, and L. Kvols, Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma. The oncologist, pp.132-139, 2005.

N. Zar, L. Holmberg, and E. Wilander, Survival in small intestinal adenocarcinoma, European Journal of Cancer, vol.32, issue.12, pp.2114-2123, 1990.
DOI : 10.1016/S0959-8049(96)00244-4

V. Verwaal, S. Van-ruth, and E. De-bree, Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer, Journal of Clinical Oncology, vol.21, issue.20, pp.3737-3780, 2003.
DOI : 10.1200/JCO.2003.04.187

S. Kopetz, G. Chang, and M. Overman, Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy, Journal of Clinical Oncology, vol.27, issue.22, pp.3677-83, 2009.
DOI : 10.1200/JCO.2008.20.5278

M. Veyrières, P. Baillet, and J. Hay, Factors influencing long-term survival in 100 cases of small intestine primary adenocarcinoma, The American Journal of Surgery, vol.173, issue.3, pp.237-246, 1997.
DOI : 10.1016/S0002-9610(97)89599-2

S. John, S. Robinson, and S. Rehman, Prognostic Factors and Survival after Resection of Colorectal Liver Metastasis in the Era of Preoperative Chemotherapy: An 11-Year Single-Centre Study, Digestive Surgery, vol.30, issue.4-6, pp.4-6293, 2013.
DOI : 10.1159/000354310

M. Rees, P. Tekkis, and F. Welsh, Evaluation of Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer, Annals of Surgery, vol.247, issue.1, pp.125-160, 2008.
DOI : 10.1097/SLA.0b013e31815aa2c2

A. Andreou, T. Aloia, and A. Brouquet, Margin Status Remains an Important Determinant of Survival After Surgical Resection of Colorectal Liver Metastases in the Era of Modern Chemotherapy, Annals of Surgery, vol.257, issue.6, pp.1079-88, 2013.
DOI : 10.1097/SLA.0b013e318283a4d1

L. Viganò, L. Capussotti, and R. Lapointe, Early Recurrence After Liver Resection for Colorectal Metastases: Risk Factors, Prognosis, and Treatment. A LiverMetSurvey-Based Study of 6,025 Patients, Annals of Surgical Oncology, vol.26, issue.6, pp.1276-86, 2013.
DOI : 10.1245/s10434-013-3421-8

T. André, C. Boni, and M. Navarro, Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial, Journal of Clinical Oncology, vol.27, issue.19, pp.3109-3125, 2009.
DOI : 10.1200/JCO.2008.20.6771

G. Yothers, O. Connell, M. Allegra, and C. , Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses, Journal of Clinical Oncology, vol.29, issue.28, pp.3768-74, 2011.
DOI : 10.1200/JCO.2011.36.4539

D. Haller, J. Tabernero, and J. Maroun, Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer, Journal of Clinical Oncology, vol.29, issue.11, pp.1465-71, 2011.
DOI : 10.1200/JCO.2010.33.6297

B. Nordlinger, H. Sorbye, and B. Glimelius, Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial, The Lancet, vol.371, issue.9617, pp.1007-1023, 2008.
DOI : 10.1016/S0140-6736(08)60455-9